Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Net Margin (2012 - 2026)

Updated

Grace Therapeutics (GRCE) posted Net Margin of -11198.58% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 9550.54 percentage points from -1648.04% a year earlier and down 10344.96 percentage points from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Net Margin (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Margin at Grace Therapeutics was -3245.75%, down 1766.12 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was -1137.66%, up 176.62 percentage points from FY2025.

  • Annual Net Margin shows a five-year change of +8902.13 percentage points (FY2021 to FY2026).
  • In prior fiscal years, Grace Therapeutics' Net Margin was -1314.29% in FY2025 (+154.63 pp) and -1468.91% in FY2024.
  • The fiscal Q1 2027 figure stands as the lowest quarterly Net Margin since fiscal Q3 2016.
  • On a year-over-year basis, Net Margin increased in two of the last five quarters, with an average year-over-year change of -1603.63 percentage points.
  • According to Business Quant data, Net Margin for the three prior fiscal quarters was -853.62% (Q4 2026), -1345.93% (Q3 2026) and -545.35% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 0.83%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 24.24%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 28.01%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 20.69%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 37.28%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 29.27%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 19.55%
10 Grace Therapeutics 35.10 Mn -35.61 Mn - -1,383.77%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11,198.58%
Mar 31, 2026 -853.62%
Dec 31, 2025 -1,345.93%
Sep 30, 2025 -545.35%
Jun 30, 2025 -1,648.04%
Mar 31, 2025 345.65%
Dec 31, 2024 -3,271.65%
Sep 30, 2024 -1,885.71%
Jun 30, 2024 -1,113.62%
Mar 31, 2021 -4,909.57%
Dec 31, 2020 -3,975.31%
Mar 31, 2018 -0.55%
Nov 30, 2016 -143.86%
Aug 31, 2016 -63,790.74%
May 31, 2016 -109,210.53%
Nov 30, 2015 -43,180.92%
Aug 31, 2015 -17,725.46%
May 31, 2015 -18,737.80%
Feb 28, 2015 -1,298.31%
Nov 30, 2014 10,451.41%
API Access

Grace Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=GRCE&period=max&api_key=YOUR_API_KEY